Saturday, November 15, 2025
No Result
View All Result
Volume 2, Issue 2
International Myeloma Society
  • Home
  • Letter From the President
  • COVID Corner
  • Research Spotlight
  • Meeting Updates
  • Contact
  • Home
  • Letter From the President
  • COVID Corner
  • Research Spotlight
  • Meeting Updates
  • Contact
No Result
View All Result
International Myeloma Society
No Result
View All Result
Home Uncategorized

Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

Jesus San Miguel, MD and Evangelos Terpos, MD

August 9, 2023
in Uncategorized

Sign Up to Our Newsletter

Popular Articles

  • Updates from the IMS Annual Meeting: Basic & Translational Science

    0 shares
    Share 0 Tweet 0
  • 19th IMS Annual Meeting – Virtual Access extended to January 13!

    0 shares
    Share 0 Tweet 0
  • COVID-19 in Myeloma: What Have We Learned During the 18th IMS Annual Meeting?

    0 shares
    Share 0 Tweet 0
  • Letter from the President

    0 shares
    Share 0 Tweet 0
  • 20th IMS Annual Meeting

    0 shares
    Share 0 Tweet 0
  • Home
  • Letter From the President
  • Contact

© 2022 International Myeloma Society. All Rights Reserved - Website by Rocket Marketing.

No Result
View All Result
  • Contact
  • Home

© 2022 International Myeloma Society. All Rights Reserved - Website by Rocket Marketing.